$ULBearishHigh

Unilever McCormick deal under pressure as backlash builds

Unilever said it plans to merge its Foods business (excluding India) with McCormick in a deal worth over $40bn (€34bn), but investor confidence has been weak. The share price fell after rumours emerged and stayed below pre-rumour highs. Terry Smith exited, citing activist-driven strategy. Analysts questioned the valuation uplift, though Unilever says the board backed the deal and completion depends mainly on regulatory approval.

9/10
High
Bearish
Deal completion is described as contingent on regulatory approvals; trading catalysts likely cluster around approval progress and any board reassessment signals.
Bearish—share price remains below pre-rumor highs and a major investor exited while criticizing the strategy.

Sentiment is negative as stakeholders question the valuation and process; however completion still hinges mainly on regulatory approvals.

Unilever’s $40bn Foods merger with McCormick faces investor backlash and a depressed share price, raising deal-completion risk.

Near-term downside/volatility likely while the market tests whether the board reverses amid low confidence.

Background

Unilever announced a merger of its Foods business (excluding India) with McCormick in a deal valued at over $40bn; two months on, stakeholder confidence remains weak amid investor and employee criticism.

Why it matters

The core trading issue is whether the market’s perceived execution/valuation risk translates into a board reconsideration, or whether regulatory approval dominates and the deal proceeds.

Market relevance

Negative sentiment around a major CPG M&A deal is driving price weakness, but analysts still frame completion as likely pending regulation.

Market effects

Big Food consolidation narrative may face skepticism if this high-profile deal is delayed or re-priced by the market.

UK-listed Unilever pricing is specifically pressured; European consumer staples sentiment could remain cautious toward portfolio-simplification M&A.

A $40bn cross-border combination would be a major precedent for global CPG dealmaking, so regulatory outcomes could affect deal appetite broadly.

Alternative perspectives

Despite backlash, the board’s unanimous vote and “limited risk” of regulatory non-approval suggest the market may be over-discounting completion risk.

The article notes Unilever retains ~65% of the combined Foods entity and that Foods has strong operating margins; these fundamentals could support deal logic even if valuation uplift is debated.

Key entities

  • Unilever

    Proposed merger of its Foods business with McCormick; facing investor/employee backlash and a depressed share price.

  • McCormick & Company

    Counterparty in the proposed Foods merger; deal completion depends mainly on regulatory approvals.

  • Terry Smith

    High-profile investor who exited his Unilever stake and criticized activist-driven strategy and McCormick’s management/returns.

  • UEWC (European Works Council)

    Employee representative body raising concerns about lack of early consultation and renewed uncertainty.

Related articles

$ULLow

Completion of 2026 Share Buyback

Unilever PLC said it has completed its 2026 share buyback announced with its FY 2025 results and started on 30 April 2026. The company bought 30,703,780 ordinary shares for an aggregate market value of about €1.5 billion. Unilever also noted a latest total voting rights update filed on 1 June 2026.

$ULLow

Prediction: Unilever’s Turnaround Could Drive Shares to $75

24/7 Wall St. rates Unilever (UL) a HOLD, setting a $54.63 price target versus about $56.45, implying -3.22% and 90% confidence. The article cites UL’s FY2025 EPS of $2.59 missing consensus $2.9383 and underlying operating margin of 20%, plus oil-driven cost pressure. It notes a €1.5 billion buyback starting Q2 2026 and a bull case toward $75.79 by June 2027.

$ULMedAI 9/10

Unilever McCormick deal under pressure as backlash builds

Unilever said it plans to merge its Foods business (excluding India) with McCormick in a deal worth over $40bn (€34bn), but investor confidence has weakened. The company’s shares fell after deal rumours and remain below pre-rumour highs. Terry Smith exited, citing activist-driven strategy concerns. Analysts question the valuation uplift, though Unilever says the board voted unanimously and completion depends mainly on regulatory approval.

$RIOMed

FTSE 100 Drops 0. 95 Percent to 10, 404. 87 on May 28 as Geopolitical Tensions Hit London Markets

The FTSE 100 fell 0.95% to close at 10,404.87 on May 28, down 100.14 points, as renewed U.S.-Iran military exchanges and weaker commodity-linked stocks weighed on sentiment in London, according to the report. Mining and energy shares led declines, while defensive sectors were steadier. Trading volume was above average amid a stronger U.S. dollar and rising bond yields.